Denali Therapeutics (DNLI) Asset Utilization Ratio (2018 - 2024)

Denali Therapeutics (DNLI) has 7 years of Asset Utilization Ratio data on file, last reported at 0.0 in Q2 2024.

• Asset Utilization Ratio for Q2 2024 came in at 0.0, down 99.67% year-over-year; the trailing twelve-month figure through Jun 2024 was 0.0 (down 99.67% YoY), and the FY2023 annual result was 0.25, up 10558.38% from the prior year.
• Asset Utilization Ratio eased to 0.0 in Q2 2024 per DNLI's latest filing, from 0.22 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.28 in Q4 2023 and troughed at 0.0 in Q2 2024.
• A 5-year average of 0.13 and a median of 0.09 in 2022 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2021 and 2024: Asset Utilization Ratio soared 2499.38% in 2021, then tumbled 99.67% in 2024.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.24 in 2020, then tumbled by 90.48% to 0.02 in 2021, then soared by 239.29% to 0.08 in 2022, then surged by 254.58% to 0.28 in 2023, then plunged by 99.7% to 0.0 in 2024.
• Business Quant data shows DNLI's Asset Utilization Ratio at 0.0 in Q2 2024, 0.22 in Q1 2024, and 0.28 in Q4 2023.